X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (5) 5
aged (4) 4
alzheimer's disease (4) 4
animals (4) 4
humans (4) 4
alzheimers disease (3) 3
alzheimers-disease (3) 3
amyloid precursor protein (3) 3
primate (3) 3
af102b (2) 2
af150 (2) 2
af267b (2) 2
aged microcebes (2) 2
agonist (2) 2
alzheimer disease - drug therapy (2) 2
alzheimer disease - metabolism (2) 2
amyloid beta-peptides - metabolism (2) 2
apoptosis (2) 2
beta-protein (2) 2
brain (2) 2
cell death (2) 2
cerebral cortex - metabolism (2) 2
cerebral-cortex (2) 2
cerebrospinal-fluid (2) 2
cheirogaleidae - metabolism (2) 2
immunocytochemistry (2) 2
immunohistochemistry (2) 2
male (2) 2
memory (2) 2
microcebus-murinus (2) 2
muscarinic agonists - therapeutic use (2) 2
neurology (2) 2
neurotrophic (2) 2
receptor agonists (2) 2
secretion (2) 2
tau protein (2) 2
tau proteins - metabolism (2) 2
tau-phosphorylation (2) 2
β-amyloid (2) 2
a-beta deposition (1) 1
a-beta-40 (1) 1
activation (1) 1
adult (1) 1
aged dogs (1) 1
aged rhesus-monkeys (1) 1
ageing (1) 1
aging (1) 1
aging - metabolism (1) 1
aging - pathology (1) 1
agonists (1) 1
alzheimer disease - economics (1) 1
alzheimer disease - therapy (1) 1
alzheimer's (1) 1
alzheimer’s (1) 1
amyloid beta protein (1) 1
amyloid beta-peptides - drug effects (1) 1
amyloid beta-protein (1) 1
amyloidosis - metabolism (1) 1
amyloidosis - pathology (1) 1
angiopathy (1) 1
animal model (1) 1
apoptosis - drug effects (1) 1
assay (1) 1
beta amyloid c-terminus epitope (1) 1
beta-amyloid (1) 1
biochemistry & molecular biology (1) 1
biomedicine (1) 1
blood screening tests (1) 1
blood vessels - metabolism (1) 1
blood vessels - pathology (1) 1
brain - pathology (1) 1
brain chemistry - physiology (1) 1
canine senile plaques (1) 1
capillary-electrophoresis (1) 1
care and treatment (1) 1
cell death - drug effects (1) 1
cells (1) 1
cerebral cortex - drug effects (1) 1
cerebrovascular amyloidosis (1) 1
clinical neurology (1) 1
cognition - drug effects (1) 1
cortex (1) 1
creutzfeldt-jakob disease (1) 1
creutzfeldt-jakob syndrome - blood (1) 1
creutzfeldt-jakob-disease (1) 1
creutzfeldt–jakob disease (1) 1
cross-cultural comparison (1) 1
cyclic amplification (1) 1
deposits (1) 1
detect (1) 1
disease models, animal (1) 1
drug evaluation, preclinical (1) 1
drug therapy (1) 1
epidermal growth factor - metabolism (1) 1
female (1) 1
france (1) 1
health aspects (1) 1
health policy - economics (1) 1
health policy - trends (1) 1
hematology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Molecular Neuroscience, ISSN 0895-8696, 08/2002, Volume 19, Issue 1-2, pp. 145 - 153
The M-1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren's Syndrome), AF150(S) and AF267B-1) are neurotrophic and... 
Agonist | Memory | AF102B | AF150(S) | AF267B | Amyloid precursor protein | muscarinic | Tau protein | Cell death | Aged microcebes | Neurotrophic | β-amyloid | Alzheimer's | Apoptosis | ACTIVATION | memory | RECEPTOR AGONISTS | apoptosis | MICROCEBUS-MURINUS | CEREBROSPINAL-FLUID | TAU-PHOSPHORYLATION | beta-amyloid | amyloid precursor protein | BETA-PROTEIN | neurotrophic | CELLS | cell death | BIOCHEMISTRY & MOLECULAR BIOLOGY | agonist | aged microcebes | NEUROSCIENCES | CEREBRAL-CORTEX | M-1 muscarinic | SECRETION | tau protein | Water | Spinal Cord - drug effects | Spinal Cord - metabolism | Apoptosis - drug effects | Muscarinic Agonists - pharmacology | Muscarinic Agonists - therapeutic use | Amyloid beta-Peptides - drug effects | tau Proteins - metabolism | Receptors, Muscarinic - metabolism | Spiro Compounds - therapeutic use | Hippocampus - drug effects | Thiazoles - therapeutic use | PC12 Cells | Cerebral Cortex - metabolism | Receptors, Muscarinic - drug effects | Piperidines - pharmacology | Amyloid beta-Peptides - metabolism | Models, Animal | Cell Death - drug effects | Cerebral Cortex - drug effects | Phosphorylation - drug effects | Drug Evaluation, Preclinical | Nerve Growth Factor - metabolism | Alzheimer Disease - drug therapy | Rats | Epidermal Growth Factor - metabolism | Cognition - drug effects | Maze Learning - drug effects | Receptor, Muscarinic M1 | Hippocampus - metabolism | Animals | Piperidines - therapeutic use | Alzheimer Disease - metabolism | Mice | Thiazoles - pharmacology | Oxidative Stress - drug effects | Spiro Compounds - pharmacology | Drug therapy | Alzheimer's disease | Amyloid beta-protein | Care and treatment | Research | Health aspects | Agonists (Biochemistry) | Alzheimers disease | Rodents
Journal Article
NEUROBIOLOGY OF DISEASE, ISSN 0969-9961, 02/2000, Volume 7, Issue 1, pp. 1 - 8
Recent reports have shown that amyloid beta deposits in the brains of Alzheimer's disease patients consist mainly of two distinct species of amyloid beta... 
A-BETA-40 | ageing | PROTEIN | ALZHEIMERS-DISEASE | brain | IDENTIFICATION | AGED RHESUS-MONKEYS | NEUROSCIENCES | primate | beta amyloid C-terminus epitope | microcebe | A-BETA DEPOSITION | MICROGLIA | CANINE SENILE PLAQUES | ANGIOPATHY
Journal Article
Journal of Molecular Neuroscience, ISSN 0895-8696, 8/2002, Volume 19, Issue 1, pp. 145 - 153
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren’s Syndrome), AF150(S) and AF267B—1) are neurotrophic and... 
neurotrophic | Neurosciences | memory | cell death | AF102B | AF150(S) | AF267B | apoptosis | agonist | aged microcebes | M 1 muscarinic | Alzheimer’s | Neurology | Biomedicine | amyloid precursor protein | tau protein | β-amyloid
Journal Article
Journal of Neural Transmission, Supplement, ISSN 0303-6995, 2002, Issue 62, pp. 189 - 202
The M1 muscarinic agonists AF102B, AF150(S) & AF267B - i) restored cognitive impairments in several animal models for AD with an excellent safety margin; ii)... 
IN-VITRO | RECEPTOR AGONISTS | M1 AGONIST | MICROCEBUS-MURINUS | BETA-PROTEIN | AMYLOID PRECURSOR PROTEIN | SECRETION | CEREBROSPINAL-FLUID | TAU-PHOSPHORYLATION | NEUROSCIENCES | CEREBRAL-CORTEX | Alzheimer Disease - drug therapy | Aged | Humans | Muscarinic Agonists - therapeutic use
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 1994, Volume 15, Issue 2, pp. 215 - 220
The deposition of amyloid beta (Aβ) protein in the brain has been demonstrated immunocytochemically in the small Lemurian primate Microcebus murinus. Both... 
Lemurian | Senile plaques | Amyloid beta protein (Aβ) | Immunocytochemistry | Cerebrovascular amyloidosis | Primate | Alzheimer's disease | IMMUNOCYTOCHEMISTRY | PRECURSOR | PRIMATE | LEMURIAN | ALZHEIMERS DISEASE | ALZHEIMERS-DISEASE | AMYLOID BETA PROTEIN (A-BETA) | CEREBROVASCULAR AMYLOIDOSIS | NEUROSCIENCES | SENILE PLAQUES | DEPOSITS | CORTEX | NEURITES | AGED DOGS | MONKEYS
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 2009, Volume 5, Issue 1, pp. 61 - 65
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.